Reagenzien und Instrumente für die Immunologie Zellbiologie und Molekularbiologie
 
> Phosal 50 PG [774594-96-6]

Phosal 50 PG [774594-96-6]

Drucken Drucken
Melden Sie sich an

Katalog-Nummer HY-Y1903-25mL

Size : 25mL

Marke : MedChemExpress

Contact local distributor :


Telefonnummer : +1 850 650 7790

Phosal 50 PG is a cosolvent (standardised phosphatidylcholine concentrate). Phosal 50 PG as a carrier for lipophilic compounds, can improve the absorption, efficacy and therapeutic index of the active ingredient.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Phosal 50 PG Chemische Struktur

Phosal 50 PG Chemische Struktur

CAS. Nr. : 774594-96-6

This product is a controlled substance and not for sale in your territory.

Based on 3 publication(s) in Google Scholar

Beschreibung

Phosal 50 PG is a cosolvent (standardised phosphatidylcholine concentrate). Phosal 50 PG as a carrier for lipophilic compounds, can improve the absorption, efficacy and therapeutic index of the active ingredient[1].

In Vivo

Phosal 50 PG is usually used as a cosolvent.
Navitoclax (HY-10087) (100 mg/kg, once a day for 21 days) is formulated in 10% ethanol, 30% polyethylene glycol 400, and 60% Phosal 50 PG and administered p.o. to mice[2].
A-1331852 (HY-19741) (25 mg/kg, daily for 10 days) is formulated in 2.5% DMSO, 10% ethanol, 27.5% PEG 300, and 60% Phosal 50 PG and administered p.o. to mice[3].
Venetoclax (HY-15531) (100 mg/kg, daily for 10 days) is formulated in 10% ethanol, 30% PEG 400, 60% Phosal 50 PG and administered p.o. to mice[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
CAS. Nr.

774594-96-6
Unlabeled CAS

Appearance

Liquid

Color

Light yellow to yellow

SMILES

[Phosal 50 PG]
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

4°C, protect from light
Reinheit & Dokumentation

COA (243 KB)

Handling Instructions (2659 KB)
Verweise

  • [1]. Khani S, et al. Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF). AAPS PharmSciTech. 2014 Feb;15(1):96-102.  [Content Brief]

  • [1]. Khani S, et al. Improved oral bioavalability of mebudipine upon administration in PhytoSolve and Phosal-based formulation (PBF). AAPS PharmSciTech. 2014 Feb;15(1):96-102.

  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Phosal 50 PG Related Classifications

  • Others
  • Biochemical Assay Reagents

  • Molaritätsrechner

  • Verdünnungsrechner

Die Formel zur Berechnung von Molaritäten

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)

Diese Gleichung wird häufig abgekürzt als: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Phosal 50 PG774594-96-6Biochemical Assay Reagentslipophilic compoundsabsorptionefficacytherapeutic indexphosphatidylcholineInhibitorinhibitorinhibit

Sie könnten auch an folgenden Produkten interessiert sein:



Katalog-Nummer
Beschreibung
Cond.
Preis zzgl. MwSt.
HY-10087-100mg
Navitoclax [923564-51-6]
 100mg 
HY-19741-50mg
A-1331852 [1430844-80-6]
 50mg 
HY-15142-500mg
Doxorubicin (hydrochloride) [25316-40-9]
 500mg